Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026)

Zimmer Biomet Holdings has reported Income from Continuing Operations for 18 years, with the latest figure at $199.6 million in Q2 2026.

• On a quarterly basis, Income from Continuing Operations rose 30.12% year-over-year to $199.6 million in Q2 2026; TTM through Jun 2026 was $847.3 million, a 8.98% increase from a year earlier, with the FY2025 full-year figure at $745.4 million, down 13.07% from the prior year.
• Income from Continuing Operations was $199.6 million for Q2 2026 at Zimmer Biomet Holdings, down from $238.3 million in the prior quarter.
• The five-year high for Income from Continuing Operations was $323.4 million in Q4 2023, with the low at $47.8 million in Q4 2022.
• Average Income from Continuing Operations over 5 years is $191.0 million, with a median of $193.3 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations tumbled 62.07% in 2022, then jumped 576.57% in 2023.
• Over 5 years, Income from Continuing Operations stood at $47.8 million in 2022, then surged by 576.57% to $323.4 million in 2023, then sank by 40.51% to $192.4 million in 2024, then dropped by 7.38% to $178.2 million in 2025, then gained by 12.01% to $199.6 million in 2026.
• The last three Income from Continuing Operations figures came in at $199.6 million (Q2 2026), $238.3 million (Q1 2026), and $178.2 million (Q4 2025), per Business Quant data.